Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · IEX Real-Time Price · USD
8.86
+0.08 (0.91%)
May 3, 2024, 12:03 PM EDT - Market open
Coya Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Coya Therapeutics stock have an average target of 19, with a low estimate of 14 and a high estimate of 28. The average target predicts an increase of 114.45% from the current stock price of 8.86.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for COYA stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +58.01% | Apr 29, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $11 → $14 | Strong Buy | Maintains | $11 → $14 | +58.01% | Mar 20, 2024 |
| EF Hutton | EF Hutton | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +216.03% | Aug 9, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +24.15% | Aug 9, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +24.15% | Jul 18, 2023 |
Financial Forecast
Revenue This Year
8.57M
from 6.00M
Increased by 42.75%
Revenue Next Year
10.20M
from 8.57M
Increased by 19.05%
EPS This Year
-0.87
from -0.79
EPS Next Year
-1.63
from -0.87
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 8.8M | 10.5M | 31.5M |
| Avg | 8.6M | 10.2M | 30.6M |
| Low | 8.2M | 9.8M | 29.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 46.9% | 22.5% | 208.8% |
| Avg | 42.7% | 19.0% | 200.0% |
| Low | 37.1% | 14.4% | 188.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.89 | -1.68 | -0.46 |
| Avg | -0.87 | -1.63 | -0.45 |
| Low | -0.83 | -1.57 | -0.43 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.